Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.

Vaccine - 23 May 2014

Gromowski Gregory D, Firestone Cai-Yen, Hanson Christopher T, Whitehead Stephen S

Abstract excerpt

Japanese encephalitis virus (JEV) is a leading cause of viral encephalitis worldwide and vaccination is one of the most effective ways to prevent disease. A suitable live-attenuated JEV vaccine could be formulated with a live-attenuated tetravalent dengue vaccine for the control of these viruses in endemic areas. Toward this goal, we generated chimeric virus vaccine candidates by replacing the precursor membrane...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dengue Virus
Share to Encephalitis, Japanese
Share to Encephalitis Virus, Japanese

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA Helicases

Share to Serine Endopeptidases

Share to Vero Cells

Share to Viral Envelope Proteins

Share to Viral Nonstructural Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 24699473
DOI: 10.1016/j.vaccine.2014.03.062
PMCID: PMC4083695

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.PMID 24699473Read ↗

A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman PrimatesSemantic proximity Read ↗

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.Semantic proximity Read ↗

Development of New Vaccines against Dengue Fever and Japanese EncephalitisSemantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese EncephalitisSemantic proximity Read ↗

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1Semantic proximity Read ↗

Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological PropertiesSemantic proximity Read ↗

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.Semantic proximity Read ↗

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.Semantic proximity Read ↗

Development of a Recombinant Vaccine Against Japanese EncephalitisSemantic proximity Read ↗

Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)Semantic proximity Read ↗

A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.